Fibromyalgia Trial, Recruiting (NCT05357157)

Fibromyalgia Trial, Recruiting NCT05357157 Sponsor: University of Crete Condition: Fibromyalgia

Printed from Voxsanity (voxsanity.com.au) — NCT05357157 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Fibromyalgia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must agree to take part and give your consent
You must be over 18 years old
You must have been diagnosed with fibromyalgia by a rheumatologist (a joint and muscle specialist)
You must have had widespread pain for more than 6 months
If you are taking medication for your condition, you must have been on a stable dose for at least one month before the trial starts and must stay on the same dose throughout the study

Who may not be able to join:

People who have severe (deep) depression
People who are taking a type of medication called biological agents, specifically TNF inhibitors (used for conditions like arthritis)
People who have blood-related diseases or disorders
People who have an active widespread infection in their body
People who are pregnant
People who have conditions that make electroacupuncture unsafe, including epilepsy, or those who have a pacemaker or an implanted heart device (ICD)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

This information is provided to help you understand the trial criteria only and is not medical advice. A healthcare professional at the trial site will make the final decision about whether you are eligible to participate.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +302810392994

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05357157

Sponsor: University of Crete

Phase: Not Applicable

Status: Recruiting

Condition: Fibromyalgia

Trial contact: +302810392994

More information: https://clinicaltrials.gov/study/NCT05357157

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must agree to take part and give your consent
You must be over 18 years old
You must have been diagnosed with fibromyalgia by a rheumatologist (a joint and muscle specialist)
You must have had widespread pain for more than 6 months
If you are taking medication for your condition, you must have been on a stable dose for at least one month before the trial starts and must stay on the same dose throughout the study

Who may not be able to join:

People who have severe (deep) depression
People who are taking a type of medication called biological agents, specifically TNF inhibitors (used for conditions like arthritis)
People who have blood-related diseases or disorders
People who have an active widespread infection in their body
People who are pregnant
People who have conditions that make electroacupuncture unsafe, including epilepsy, or those who have a pacemaker or an implanted heart device (ICD)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Crete

Registry

ClinicalTrials.gov

Start date

31 May 2022

Est. completion

1 December 2025

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

MOR - positive Bcells - baseline; MOR - positive Bcells - 6th session of electroacupuncture; MOR - positive Bcells - 12th session of electroacupuncture; MOR - positive Bcells - 6 months after the end of the 12th session

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov